Clinical trial
Thyroid-Associated Ophthalmopathy Subtypes and Orbital Antibodies
NCT00430547 · Barwon Health, Other · Completed
Key facts
| NCT number | NCT00430547 |
|---|---|
| Title | Thyroid-Associated Ophthalmopathy Subtypes and Orbital Antibodies |
| Official title | Thyroid-Associated Ophthalmopathy Subtypes and Orbital Antibodies |
| Lead sponsor | Barwon Health, Other |
| Collaborators | University of Melbourne National Health and Medical Research Council, Australia |
| Status | Completed |
| Study type | Interventional |
| Conditions | Graves' Ophthalmopathy |
| Intervention type | Drug |
| Interventions | Carbimazole, radio-active iodine (I131) |
| Enrollment | 60 |
| Start date | Aug 1, 2003 |
| Completion | Jan 1, 2006 |
| First posted | Feb 2, 2007 |
| Last update posted | Feb 2, 2007 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: